Senate bill would cap monthly insulin costs at $35 for Americans with commercial insurance

A bill proposed in the U.S Senate would limit out-of-pocket insulin costs for Americans with diabetes who have commercial health insurance, according to a press release.

On April 20, U.S. Sen. Jeanne Shaheen (D-NH) and Sen. Susan Collins (R-ME) introduced the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2023. Read the full story in Healio.